Twist Bioscience
TWST
85 hedge funds and large institutions have $402M invested in Twist Bioscience in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 32 increasing their positions, 4 reducing their positions, and 5 closing their positions.
740% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 5
700% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 4
192% more capital invested
Capital invested by funds: $138M → $402M (+$264M)
73% more funds holding
Funds holding: 49 → 85 (+36)
21.42% more ownership
Funds ownership: 21.43% → 42.85% (+21%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| 1 |
BlackRock
New York
|
+$30.9M |
| 2 |
JP Morgan Chase
New York
|
+$25.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.3M |
| 4 |
Millennium Management
New York
|
+$16.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.3M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.1M |
| 2 |
A
Apoletto
Road Town, Tortola,
British Virgin Islands
|
-$10.5M |
| 3 |
AG
Artal Group
Luxembourg
|
-$1.32M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.09M |
| 5 |
Barclays
London,
United Kingdom
|
-$403K |
TWST Hedge Fund Activity: Q2 2019 in Review
85 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q2 2019, worth a combined $402M — up 192% from $138M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new TWST positions and 5 closed out — a net gain of 37 holders — while 32 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $30.9M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.
- 85 institutional investors held Twist Bioscience (TWST) as of Q2 2019, up from 49 in Q1 2019.
- Funds reported $402M of Twist Bioscience stock for Q2 2019, up 192% quarter-over-quarter.
- 42 funds opened new Twist Bioscience positions in Q2 2019 and 5 closed out, a net change of +37 holders.
- The largest Twist Bioscience buyer in Q2 2019 was BlackRock, an estimated $30.9M added.
- The largest Twist Bioscience seller in Q2 2019 was Fidelity Investments, an estimated $16.1M sold.
Based on aggregated 13F filings for Q2 2019.